“How statins could be protective against pancreatic cancer” – The New Daily

Originally Posted on The New Daily

“Just about every cancer is a nightmare, largely because of the uncertainty and the rigours of treatment.

Still, overall, more people are surviving that magic five years, depending on cancer type.

Pancreatic cancer, however, remains stubbornly resistant to becoming a good news story. The five-year survival rate stands at about 13 per cent.

Which is woeful, but actually much better than it used to be. Thirty years ago, the survival rate was less than four per cent.

Most pancreatic cancers are driven by cell mutations in what’s known as the KRAS gene. For these, there are no treatments available… “

Read Full Article